NYU Langone Health

Researchers

• JGJonathan Garnier

Running trials

• Not yet recruiting

  Cardiovascular Disease Multimorbidity

  NCT07909395· NYU Langone Health· Source

• Not yet recruiting

  South Asians With Type 2 Diabetes at Risk for Depression

  NCT07219667· NYU Langone Health· Source

• Not yet recruiting

  Kidney RISE: Randomized Integrated Supportive CarE Trial

  NCT07741357· NYU Langone Health· Source

• Not yet recruiting

  Optimizing Care For Management Of Hard To Control Hypertension In Low-Income Patients Across Family Health Centers In New York City

  NCT07703423· NYU Langone Health· Source

• Not yet recruiting

  Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes

  NCT07278531· NYU Langone Health· Source

• Not yet recruiting

  Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

  NCT05558267· NYU Langone Health· Source

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

• Not yet recruiting

  A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

  NCT07409350· NYU Langone Health· Source

• Not yet recruiting

  Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation

  NCT06637839· NYU Langone Health· Source

• Not yet recruiting

  Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

  NCT07723469· Phase 3· SURGE Therapeutics· Source

• Not yet recruiting

  Surgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM)

  NCT07927491· Phase 1· NYU Langone Health· Source

• Not yet recruiting

  Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies

  NCT07862738· NYU Langone Health· Source

• Not yet recruiting

  SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRT

  NCT07888283· NYU Langone Health· Source

• Recruiting

  Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

  NCT07696962· Phase 1· Xeno Holdings (US), LLC dba ChoironeX· Source

• Not yet recruiting

  Transcutaneous Auricular Vagal Neuromodulation Therapy (AVNT™) in Chronic Kidney Disease Autonomic Dysfunction

  NCT07927478· NYU Langone Health· Source

• Not yet recruiting

  The Sleep and Weight Study

  NCT07904663· NYU Langone Health· Source

• Recruiting

  Histotripsy in Biliary Tract Cancer

  NCT07853690· NYU Langone Health· Source

• Recruiting

  A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)

  NCT07843940· Phase 1/2· Boehringer Ingelheim· Source

• Recruiting

  A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

  NCT07867080· Phase 3· 4D Molecular Therapeutics· Source

• Recruiting

  Visual Hallucinations in Lewy Body Diseases

  NCT07849413· NYU Langone Health· Source

• Recruiting

  HEALTH Home Urinalysis Testing

  NCT07823478· NYU Langone Health· Source

• Recruiting

  Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

  NCT07654283· Phase 2· AusperBio Therapeutics Inc.· Source

• Not yet recruiting

  A Clinical Trial of Antiplatelets in Psoriasis

  NCT07744191· Phase 4· NYU Langone Health· Source

• Not yet recruiting

  Noise Reduction With Hearing Aids

  NCT07700043· NYU Langone Health· Source

• Not yet recruiting

  Hypoxia-targeted Radiotherapy Boost for GBM

  NCT07769918· NYU Langone Health· Source

• Recruiting

  Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

  NCT06349083· Phase 2· NYU Langone Health· Source

• Recruiting

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· Phase 3· Kardigan, Inc.· Source

• Recruiting

  Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer

  NCT07767500· NYU Langone Health· Source

• Recruiting

  A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

  NCT07298421· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

  NCT07585968· Medtronic Cardiac Ablation Solutions· Source

• Recruiting

  Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

  NCT07801664· Phase 2· NYU Langone Health· Source

• Not yet recruiting

  Sexual Health Communication Skills Training Intervention for Patients With Prostate Cancer

  NCT07655557· NYU Langone Health· Source

• Not yet recruiting

  Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

  NCT06760533· Early phase 1· NYU Langone Health· Source

• Recruiting

  A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

  NCT07533942· Phase 2· Jazz Pharmaceuticals· Source

• Recruiting

  Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)

  NCT07913347· Phase 1/2· Metagen Therapeutics, Inc.· Source

• Not yet recruiting

  Perspectives About Online Information

  NCT07631858· NYU Langone Health· Source

• Recruiting

  A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  NCT07488923· Phase 1· Moonlight Bio, Inc· Source

• Recruiting

  Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)

  NCT07567027· NYU Langone Health· Source

• Recruiting

  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  NCT07563881· Phase 3· Rapport Therapeutics Inc.· Source

• Recruiting

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· Phase 3· Immuneering Corporation· Source

• Recruiting

  tDCS: Sleep to Mood in Depression (S2M-D)

  NCT07572526· NYU Langone Health· Source

• Not yet recruiting

  AIManage Using an AI-driven CDS and Chatbot

  NCT07546357· NYU Langone Health· Source

• Not yet recruiting

  Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac

  NCT07457307· Phase 1· NYU Langone Health· Source

• Not yet recruiting

  Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma

  NCT07103525· NYU Langone Health· Source

• Recruiting

  Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

  NCT07623902· Jubaan Ltd.· Source

• Not yet recruiting

  Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

  NCT07428148· Phase 1/2· NYU Langone Health· Source

• Not yet recruiting

  Understanding the Long-term Impact of COVID-19 in Adults

  NCT07498504· NYU Langone Health· Source

• Recruiting

  Adaptability of an Undetectable = Untransmissible Model for HBV

  NCT07449091· NYU Langone Health· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  NCT07285655· Phase 3· Liquidia Technologies, Inc.· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Inhibikase Therapeutics· Source

Showing 50 of 351.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer25 recruiting
• Prostate cancer17 recruiting
• Colorectal cancer15 recruiting
• Pancreatic cancer12 recruiting
• High blood pressure11 recruiting
• Crohn's disease9 recruiting
• Head and neck cancer9 recruiting
• Ulcerative colitis9 recruiting
• Glioblastoma8 recruiting
• Ovarian cancer8 recruiting
• Type 2 diabetes8 recruiting
• Childhood cancers7 recruiting
• Chronic kidney disease7 recruiting
• Hearing loss7 recruiting
• Heart failure6 recruiting
• Parkinson disease6 recruiting
• Epilepsy5 recruiting
• Gastric and oesophageal cancer5 recruiting
• Kidney cancer5 recruiting
• Melanoma5 recruiting
• Obesity5 recruiting
• Opioid use disorder5 recruiting
• Pulmonary arterial hypertension5 recruiting
• Alzheimer disease4 recruiting
• Coronary artery disease4 recruiting
• Endometrial cancer4 recruiting
• HIV4 recruiting
• Liver and biliary tract cancer4 recruiting
• Lupus (SLE)4 recruiting
• Stroke4 recruiting
• Triple-negative breast cancer4 recruiting
• Atrial fibrillation3 recruiting
• Bladder cancer3 recruiting
• Depression3 recruiting
• Dermatomyositis and polymyositis (myositis)3 recruiting
• Mesothelioma3 recruiting
• Osteoarthritis3 recruiting
• Peripheral artery disease3 recruiting
• Psoriasis3 recruiting
• Acute myeloid leukaemia2 recruiting
• Deep vein thrombosis and pulmonary embolism2 recruiting
• Dilated cardiomyopathy2 recruiting
• Gout2 recruiting
• Hepatitis B2 recruiting
• Lewy body dementia2 recruiting
• Long COVID and ME/CFS2 recruiting
• Meningioma2 recruiting
• Metastatic breast cancer2 recruiting
• Mild cognitive impairment2 recruiting
• Multiple sclerosis2 recruiting
• Post-traumatic stress disorder (PTSD)2 recruiting
• Psoriatic arthritis2 recruiting
• Type 1 diabetes2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• ADHD1 recruiting
• Alcohol use disorder1 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• ANCA-associated vasculitis1 recruiting
• Ankylosing spondylitis1 recruiting
• Anxiety disorders (generalised anxiety)1 recruiting
• Aortic aneurysm1 recruiting
• Aortic stenosis1 recruiting
• Aplastic anaemia1 recruiting
• Brain aneurysm1 recruiting
• Bronchiectasis1 recruiting
• Cannabis use disorder1 recruiting
• Cervical cancer1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Congenital heart disease1 recruiting
• Diabetic eye disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Frontotemporal dementia1 recruiting
• Gaucher disease1 recruiting
• Giant cell arteritis1 recruiting
• Hepatitis C1 recruiting
• Hodgkin lymphoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Irritable bowel syndrome1 recruiting
• Liver cirrhosis1 recruiting
• Migraine1 recruiting
• Multiple myeloma1 recruiting
• Multiple system atrophy1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroendocrine tumours1 recruiting
• Obstructive sleep apnoea1 recruiting
• Optic neuritis1 recruiting
• Polymyalgia rheumatica1 recruiting
• Pompe disease1 recruiting
• Postpartum depression1 recruiting
• Primary biliary cholangitis1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Smoking and nicotine dependence1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Terminated

  Novel Digital Patient-Reported Outcomes Tool for Diabetes Management

  NCT05884775· NYU Langone Health· Source

• Withdrawn

  Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

  NCT07179770· Phase 1· NYU Langone Health· Source

• Terminated

  Paired Vagus Nerve Stimulation Mechanisms

  NCT06716112· NYU Langone Health· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

• Withdrawn

  Behavioral Nudge in Colorectal Cancer Screening

  NCT06796049· NYU Langone Health· Source

• Completed

  Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs

  NCT06632054· NYU Langone Health· Source

• Completed

  Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

  NCT06457152· NYU Langone Health· Source

• Completed

  The Protrieve PROTECTOR Study

  NCT06495996· Inari Medical· Source

• Completed

  Fatigue Reduction in Chronic Kidney Disease (CKD)

  NCT06768983· NYU Langone Health· Source

• Completed

  A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

  NCT06676072· Abbott Medical Devices· Source

• Completed

  Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

  NCT06576427· Jupiter Endovascular· Source

• Completed

  Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations

  NCT06307340· NYU Langone Health· Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Mannkind Corporation· Source

• Terminated

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  NCT06488911· Phase 3· Intercept Pharmaceuticals· Source

• Withdrawn

  Ladarixin With Sotorasib in Advanced NSCLC - Phase II

  NCT05815186· Phase 2· NYU Langone Health· Source

• Completed

  The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale

  NCT06338592· University of Utah· Source

• Completed

  A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

  NCT06280391· Phase 2· Sanofi· Source

• Completed

  Optimizing Music-Based Interventions for Stroke

  NCT06215703· NYU Langone Health· Source

• Completed

  Exoskeletal Support in Stroke

  NCT05996198· NYU Langone Health· Source

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· GB002, Inc.· Source

• Completed

  Study of the Aliviado DSD Caregiving Mastery Program

  NCT05630014· NYU Langone Health· Source

• Completed

  A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF

  NCT06144632· Biosense Webster, Inc.· Source

• Terminated

  Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

  NCT05712694· Phase 3· Polaris Group· Source

• Completed

  Study of DF6215 in Patients With Advanced Solid Tumors

  NCT06108479· Phase 1· Dragonfly Therapeutics· Source

• Completed

  NYU Langone Health Headache Center Learning Migraine Self-Management Techniques Study

  NCT06077812· NYU Langone Health· Source

• Completed

  Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

  NCT06000501· Phase 4· NYU Langone Health· Source

• Completed

  Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection

  NCT06652568· ThinkSono, Ltd.· Source

• Withdrawn

  Assessing Optimal XR-Buprenorphine Initiation Points in Jail

  NCT05481112· Phase 4· NYU Langone Health· Source

• Completed

  A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

  NCT06000410· Phase 3· Organogenesis· Source

• Completed

  Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

  NCT06060665· Phase 3· Gilead Sciences· Source

• Completed

  Stroke and Anxiety Reduction

  NCT06013982· NYU Langone Health· Source

• Completed

  Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

  NCT05776225· United Therapeutics· Source

• Completed

  Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue

  NCT06305364· Jubaan Ltd.· Source

• Completed

  Time Restricted Eating for Weight Loss Maintenance

  NCT05742165· NYU Langone Health· Source

• Completed

  FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter

  NCT05858905· Shockwave Medical, Inc.· Source

• Completed

  A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

  NCT05774184· Phase 2· Celldex Therapeutics· Source

• Completed

  Daratumumab in STK11 Mutated NSCLC

  NCT05807048· Phase 2· NYU Langone Health· Source

• Terminated

  Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

  NCT05812274· Columbia University· Source

• Completed

  UB-312 in Patients With Synucleinopathies

  NCT05634876· Phase 1· NYU Langone Health· Source

• Completed

  Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

  NCT05643196· Phase 2· NYU Langone Health· Source

• Completed

  Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

  NCT05757791· Phase 2· NYU Langone Health· Source

• Terminated

  Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

  NCT05721222· Phase 1/2· Genmab· Source

• Completed

  A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

  NCT05717686· Phase 1· AusperBio Therapeutics Inc.· Source

• Terminated

  NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma

  NCT05664217· Phase 2/3· Nektar Therapeutics· Source

• Terminated

  A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

  NCT05370508· Phase 1/2· SonALAsense, Inc.· Source

• Completed

  Level of Physical Activity and Fear Learning

  NCT05203731· NYU Langone Health· Source

• Completed

  Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

  NCT05571592· Phase 2· NYU Langone Health· Source

• Terminated

  Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC

  NCT05691829· Phase 2· NYU Langone Health· Source

• Completed

  Platelets in Pregnancy

  NCT06194643· NYU Langone Health· Source

• Completed

  At-Home Gait Assessment

  NCT05724901· NYU Langone Health· Source

Showing 50 of 149.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke143 works · 13 trials
• Lung cancer120 works · 49 trials
• Obesity116 works · 11 trials
• Alzheimer disease91 works · 9 trials
• Prostate cancer72 works · 23 trials
• Osteoarthritis71 works · 8 trials
• Epilepsy69 works · 11 trials
• HIV68 works · 6 trials
• Pancreatic cancer65 works · 20 trials
• Melanoma50 works · 12 trials
• Chronic kidney disease44 works · 10 trials
• Deep vein thrombosis and pulmonary embolism42 works · 7 trials
• Glioblastoma38 works · 9 trials
• Multiple sclerosis37 works · 8 trials
• Endometrial cancer29 works · 7 trials
• Hypertrophic cardiomyopathy28 works · 5 trials
• Crohn's disease27 works · 16 trials
• Multiple myeloma27 works · 4 trials
• ADHD26 works · 2 trials
• Brain metastases25 works · 0 trials
• Cervical cancer25 works · 6 trials
• Ulcerative colitis23 works · 14 trials
• Obstructive sleep apnoea22 works · 2 trials
• Migraine22 works · 2 trials
• Acute lymphoblastic leukaemia20 works · 2 trials
• Lupus (SLE)17 works · 8 trials
• Hydrocephalus16 works · 2 trials
• Meningioma16 works · 3 trials
• Hidradenitis suppurativa14 works · 0 trials
• Opioid use disorder14 works · 8 trials